91
Views
6
CrossRef citations to date
0
Altmetric
Injection Drug Use

Factors Associated with Recent-Onset Injection Drug Use among Drug Users in Pakistan

, , , , &
Pages 853-870 | Published online: 03 Jul 2009

References

  • Baqi S., Nabi N., Hasan S. N., Khan A. J., Pasha O., Kayani N., et al. HIV antibody seroprevalence and associated risk factors in sex workers, drug users, and prisoners in Sindh, Pakistan. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 1998; 18: 73–79
  • Beyrer C. Human immunodeficiency virus (HIV) infection rates and heroin trafficking: Fearful symmetries. Bulletin on Narcotics 2002; 14: 103–116
  • Beyrer C., Razak M. H., Lisam K., Chen J., Lui W., Yu X. F. Overland heroin trafficking routes and HIV-1 spread in South and South-east Asia. AIDS 2000; 14: 75–83
  • Bravo M. J., Barrio G., de la Fuente L., Royuela L., Domingo L., Silva T. Reasons for selecting an initial route of heroin administration and for subsequent transitions during a severe HIV epidemic. Addiction 2003; 98: 749–760
  • Clatts M. C., Goldsamt L., Neaigus A., Welle D. L. The social course of drug injection and sexual activity among YMSM and other high-risk youth: An agenda for future research. Journal of Urban Health 2003; 80: iii26–iii39
  • Day C., Topp L., Rouen D., Darke S., Hall W., Dolan K. Decreased heroin availability in Sydney in early 2001. Addiction 2003; 98: 93–95
  • Degenhardt L., Conroy E., Day C., Gilmour S., Hall W. The impact of a reduction in drug supply on demand for and compliance with treatment for drug dependence. Drug and Alcohol Dependence 2005; 79: 129–135
  • Des Jarlais D. C., Casriel C., Friedman S. R., Rosenblum A. AIDS and the transition to illicit drug injection—Results of a randomized trial prevention program. British Journal of Addictions 1992; 87: 493–498
  • Des Jarlais D. C., Friedman S. R., Choopanya K., Vanichseni S., Ward T. P. International epidemiology of HIV and AIDS among injecting drug users. AIDS 1992; 6: 1053–1068
  • Dorabjee J., Samson L. A multi-centre rapid assessment of injecting drug use in India. International Journal of Drug Policy 2000; 11: 99–112
  • Farrell G., Thorne J. Where have all the flowers gone?: Evaluation of a law enforcement crackdown against opium poppy cultivation in Afghanistan. International Journal of Drug Policy 2005; 16: 81–91
  • Friedman S. R., Des Jarlais D. C. HIV among drug injectors: The epidemic and the response. AIDS Care 1991; 3: 239–250
  • Fuller C. M., Vlahov D., Arria A. M., Ompad D. C., Garfein R., Strathdee S. A. Factors associated with adolescent initiation of injection drug use. Public Health Reports 2001; 116: 136–145, (Suppl. 1)
  • Fuller C. M., Vlahov D., Latkin C. A., Ompad D. C., Celentano D. D., Strathdee S. A. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndrome 2003; 32: 86–93
  • Khan A. J., Luby S. P., Fikree F., Karim A., Obaid S., Dellawala S., et al. Unsafe injections and the transmission of hepatitis B and C in a periurban community in Pakistan. Bulletin of the World Health Organization 2000; 78: 956–963
  • Khawaja Z. A., Gibney L., Ahmed A. J., Vermund S. H. HIV/AIDS and its risk factors in Pakistan. AIDS 1997; 11: 843–848
  • Kumar M. S., Mudaliar S., Daniels D. Community-based outreach HIV intervention for street-recruited drug users in Madras, India. Public Health Reports 1998; 113: 58–66, (Suppl. 1)
  • Lakshman M., Nichter M. Contamination of medicine injection paraphernalia used by registered medical practitioners in south India: An ethnographic study. Social Science and Medicine 2000; 51: 11–28
  • Latkin C. A. Outreach in natural settings: the use of peer leaders for HIV prevention among injecting drug users' networks. Public Health Reports 1998; 113: 151–159, (Suppl. 1)
  • Latkin C. A., Mandell W., Vlahov D., Oziemkowska M., Celentano D. D. The long-term outcome of a personal network-oriented HIV prevention intervention for injection drug users: The SAFE study. American Journal of Community Psychology 1996; 24: 341–364
  • Luby S. P., Qamruddin K., Shah A. A., Omair A., Pahsa O., Khan A. J., et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad, Pakistan. Epidemiology and Infection 1997; 119: 349–356
  • Neaigus A., Miller M., Friedman S. R., Hagen D. L., Sifaneck S. J., Ildefonso G., et al. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors. Addiction 2001; 96: 847–860
  • Parfitt T. Drug addiction and HIV infection on rise in Tajikistan. Lancet 2003; 362: 1206
  • Poshyachinda V. Drug injecting and HIV infection among the population of drug abusers in Asia. Bulletin on Narcotics 1993; 45: 77–90
  • Raglow G. J., Luby S. P., Nabi N. Therapeutic injections in Pakistan: From the patients' perspective. Tropical Medicine and International Health 2001; 6: 69–75
  • Rajasekaran M., Sivagnanam G., Thirumalaikolundusubramainan P., Namasivayam K., Ravindranath C. Injection practices in southern part of India. Public Health 2003; 117: 208–213
  • Reid G., Costigan G. Revisiting “The Hidden Epidemic”: A Situation Assessment of Drug Use in Asia in the context of HIV/AIDS. The Center for Harm Reduction, the Burnet Institute, Victoria 2002
  • Roy E., Haley N., Leclerc P., Cedras L., Blais L., Boivin J. F. Drug injection among street youths in Montreal: Predictors of initiation. Journal of Urban Health 2003; 80: 92–105
  • Sarkar S., Das N., Panda S., Naik T. N., Sarkar K., Singh B. C., et al. Rapid spread of HIV among injecting drug users in north-eastern states of India. Bulletin on Narcotics 1993; 45: 91–105
  • Strathdee S. A., Zafar T., Brahmbhatt H., Baksh A., ul-Hasan S. Rise in needle sharing among injection drug users in Pakistan during the Afghanistan war. Drug and Alcohol Dependence 2003; 71: 17–24
  • Topp L., Day C., Degenhardt L. Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. Drug and Alcohol Dependence 2003; 70: 275–286
  • United Nations Drug Control Programme Global Assessment Programme on Drug Abuse, Narcotics Control Division. Drug abuse in Pakistan. Results from the year 2000 National Assessment. United Nations Office for Drug Control and Crime Prevention. 2002, http://www.unodc.org/pdf/publications/afg_opium_economy_2003.pdf Retrieved May 19, 2005, from
  • United Nations Office for Drug Control and Crime Prevention. Illicit drugs situation in the regions neighbouring Afghanistan and the response of the ODCCP. 2002, http://www.unodc.org/pdf/afg/afg_drug-situation_2002-10-01_1.pdf Retrieved May 19, 2005, from
  • United Nations Office for Drug Control and Crime Prevention, United Nations Office on AIDS. Baseline study of the relationship between injecting drug use, HIV and hepatitis C among male injecting drug users in Lahore. 1999, http://www.unodc.org/pdf/pakistan/study_1999-12-31_1.pdf Retrieved May 19, 2005, from
  • United Nations Office on Drugs and Crime. The opium economy in Afghanistan: An international problem. 2003, http://www.unodc.org/pdf/publications/afg_opium_economy_2003.pdf Retrieved May 19, 2005, from
  • van Ameijden E. J., van den Hoek J. A., Hartgers C., Coutinho R. A. Risk factors for the transition from noninjection to injection drug use and accompanying AIDS risk behavior in a cohort of drug users. American Journal of Epidemiology 1994; 139: 1153–1163
  • Weatherburn D., Jones C., Freeman K., Makkai T. Supply control and harm reduction: Lessons from the Australian heroin “drought.”. Addiction 2003; 98: 83–91
  • Zafar T., Brahmbhatt H., Imam G., ul-Hasan S., Strathdee S. A. HIV knowledge and risk behaviors among Pakistani and Afghani drug users in Quetta, Pakistan. Journal of Acquired Immune Deficiency Syndrome 2003; 32: 394–398
  • Zafar T., ul-Hasan S. A sociodemographic and behavioral profile of heroin users and the risk environment in Quetta, Pakistan. International Journal of Drug Policy 2002; 13: 121–125

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.